There is never a good time for a pandemic, but covid-19 kicked doctors while we were down. Between […]

AstraZeneca saw its China sales growth slow down in the first quarter, when the coronavirus outbreak was at […]

Moderna Therapeutics has partnered with the federal government to create an mRNA-based COVID-19 vaccine it hopes to speed […]

At the J.P. Morgan Healthcare Conference in January—back when few could predict the looming destruction of COVID-19—Amgen CEO […]

Gilead Sciences scored a massive win earlier this week with its first positive data readout for investigational candidate […]

AbbVie may be working through COVID-19, but it’s pressing ahead with its Allergan merger, too—and taking stock of products […]

Antiviral drug remdesivir helps patients hospitalised with covid-19 recover faster and may also reduce mortality, according to the […]

The recommendations bring closer to approval new therapies for asthma, acute myeloid leukaemia, transfusion-dependent anaemia, diabetes, prostate cancer, […]

It is expected that the move will allow the EMA to complete its assessment of the drug significantly […]

NICE is sharing its work with initiatives such as the WHO’s Evidence Collaborative for COVID-19